Archive Newsletter

  1. 03.14.26 -- Cell & Gene Best Of February 3/14/2026
    03/14/26 Cell & Gene Newsletter
  2. 03.13.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 3/13/2026
    03/13/26 Cell & Gene Newsletter
  3. 03.12.26 -- Six Specialized Modalities Testing CDMO Readiness In 2026 3/12/2026
    03/12/26 Cell & Gene Newsletter
  4. 03.11.26 -- Are You Scaling CGT Wrong? 3/11/2026

    03/11/26 Cell & Gene Newsletter

  5. 03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards 3/11/2026
    03/11/26 Cell & Gene Newsletter
  6. 03.10.26 -- STREAM Edition: mRNA Hot Takes: Fighting Complacency And "Alternative Facts" In 2026 3/10/2026

    03/10/26 Cell & Gene Newsletter

  7. 03.10.26 -- The Real Reason We Haven't Fully Automated Cell Therapy Yet 3/10/2026
    03/10/26 Cell & Gene Newsletter
  8. 03.09.26 -- Putting Pressure On CDMOs With Herman Bozenhardt 3/9/2026
    03/09/26 Cell & Gene Newsletter
  9. 03.07.26 -- Navigating Conflicting Raw Material Preferences With Your CDMO 3/7/2026
    03/07/26
  10. 03.06.26 -- New Podcast Episodes: Therapeutic Power Of Fibroblasts, Curative Cell Therapies, Breakthrough HER2 Immunotherapy 3/6/2026
    03/06/26 Cell & Gene Newsletter